N/A
N=60
Timing of Suture Removal to Reduce Scarring in Skin Surgery
Suture Related Complication
Bottom Line
View on ClinicalTrials.gov: NCT05036785 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: The Measured Difference in POSAS and VAS Scores Between 7-day and 10-day Groups — 12.9; 16.1; 19.5; 20.3 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Timing of suture removal (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Royal Devon and Exeter NHS Foundation Trust
- Primary completion
- Oct 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Measured Difference in POSAS and VAS Scores Between 7-day and 10-day Groups |
12.9; 16.1; 19.5; 20.3; 7.2; 6.6 | — |
| SECONDARY Does Earlier Suture Removal Have an Impact (Negative or Positive) on Overall Scar Cosmesis and Wound Complication Rates (as Assessed by the Clinician and the Patient)? |
0; 0; 1; 2; 1; 1 | — |
Summary
This is a single centre prospective randomized assessor blinded parallel group feasibility study that will be undertaken in the Royal Devon and Exeter Dermatology department.
The investigators will be looking at whether timing of percutaneous suture removal after skin surgery impacts on the incidence of suture marks and overall scar cosmesis.
Eligibility Criteria
Inclusion Criteria
- Patients of 18 years old or above who had capacity to consent to surgery who were willing to attend follow-up appointments within the department
- Patients undergoing wide local excision as part of their skin cancer treatment pathway
- Lesions excised from the anterior chest or back
- Post-operative wound >/= 10mm width
- Wound could be closed with primary intention healing
Exclusion Criteria
- Inability to provide valid informed consent and/or unwilling to attend for follow-up
- Wounds where the edges could not be closely adhered with dermal sutures alone.
- Wounds requiring a flap or graft for closure.
- Patients requiring further treatment following original excision eg. Further WLE, radiotherapy etc.
Data sourced from ClinicalTrials.gov (NCT05036785). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.